We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Antinuclear Antibodies Detected by Automated Immunofluorescence

By LabMedica International staff writers
Posted on 13 May 2013
Print article
Antinuclear and anticytoplasmic antibodies are important diagnostic markers for systemic rheumatic diseases and autoimmune hepatitis.

The diagnostic performance of automated systems for image acquisition and interpretation of indirect immunofluorescence-based tests for antinuclear antibodies are increasingly being used.

Scientists at the Catholic University Leuven (Leuven, Belgium) measured by automated indirect immunofluorescence 268 consecutive samples submitted to the laboratory for antinuclear antibody testing. Included in the study were in 231 patients with a systemic rheumatic disease at the time of diagnosis, 143 blood donors, 134 patients with chronic fatigue syndrome, and 133 diseases controls whose diagnosis of systemic rheumatic disease was excluded.

Antinuclear antibodies were detected by Zenit G-Sight (A. Menarini Diagnostics, Florence, Italy), an automated system for image acquisition and interpretation of indirect immunofluorescence-based tests. The automated fluorescence microscope uses a light-emitting diode (LED) light source with a 450–490 nm bandwidth and is equipped with a motorized precision stage for up to five slides and a Charged Coupled Device (CCD) color camera.

Image acquisition by G-Sight was of high quality and the accuracy of pattern assignment was limited. There was a significant correlation between automated estimation of fluorescence intensity, known as the probability index of positivity and end-point titer. Probability index interval specific likelihood ratios for systemic rheumatic disease increased with increasing level of positivity probability. Probability indexes were higher with the transfected mitotic human epithelioid (Hep-2000) cell substrate (Immunoconcepts; Sacramento, CA, USA) than with the human epithelial cell (Hep-2) substrate. The probability indexes reached a plateau at titer 160 with the Hep-2000 substrate.

The authors concluded that G-Sight offers high quality image acquisition. The accuracy of pattern assignment is limited and needs to be further developed. There was a significant correlation between probability indexes, a measure of fluorescence intensity and antibody titer, and the probability indexes provided by G-Sight, which afforded clinically useful information. Test result specific likelihood ratios help with the interpretation of data generated by automated immunofluorescence analysis of antinuclear antibodies. The study was published on the January 16, 2013, in the journal Clinica Chimica Acta.

Related Links:
Catholic University Leuven
A. Menarini Diagnostic
Immunoconcepts


Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Basophil Activation Test
Flow CAST Kit
New
DVT/PE Test
VIDAS D-DIMER EXCLUSION II

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.